Marshall Keith W
- SEC CIK
- 0001714828
No open-market purchases or sales filed in the past year.
Current role at each company
- RXDX Prometheus Biosciences, Inc.Chief Financial Officeras of Jun 16, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Marshall Keith W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 7, 2023 (view filing) | Apr 5 | 2 days | Marshall Keith WChief Financial Officer | SSale | −10.0K | $108.42 | −$1.08M | −50.5%9.81K after | |
| Mar 8, 2023 (view filing) | Mar 6 | 2 days | Marshall Keith WChief Financial Officer | SSale | −10.0K | $122.13 | −$1.22M | −50.5%9.81K after | |
| Feb 17, 2023 (view filing) | Feb 15 | 2 days | Marshall Keith WChief Financial Officer | SSale | −5.00K | $119.38 | −$596.9K | −33.8%9.81K after | |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Marshall Keith WChief Financial Officer | SSale | −5.00K | $119.00 | −$595.0K | −33.8%9.81K after |